￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Manufacturer and background of the original drug tucatinib/tucatinib

2026-02-01 22:25:32

Check Details
Analysis of the potential of Alpelisib in the treatment of lung cancer

2026-02-01 22:25:32

Check Details
Treatment methods for post-drug resistance to lenvatinib/lenvatinib (Lenvima)

2026-02-01 22:25:32

Check Details
How effective is obeticholic acid treatment, patient feedback

2026-02-01 22:25:32

Check Details
Will Dasatinib be included in medical insurance in 2026?

2026-02-01 22:25:32

Check Details
Can baricitinib/alemin be taken for a long time and is it safe?

2026-02-01 22:25:32

Check Details
Research progress on the efficacy of tucatinib/tucatinib combined with trastuzumab

2026-02-01 22:25:32

Check Details
Criteria and precautions for discontinuing Alpelisib

2026-02-01 22:25:32

Check Details
Efficacy of lenvatinib/lenvatinib (Lenvima) in the treatment of liver cancer

2026-02-01 22:25:32

Check Details
Can Obeticholic acid be purchased in the country? Where can I buy it?

2026-02-01 22:25:32

Check Details
Dasatinib/Startacel is the first generation of targeted drugs

2026-02-01 22:25:32

Check Details
Analysis of the possibility of relapse after discontinuation of baricitinib/alemin

2026-02-01 22:25:32

Check Details
Category
相关知识